3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
5
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
3
Small Cell Lung Carcinoma
2
Thoracic Neoplasms
1
Prostatic Neoplasms
1
Mesothelioma
1
EGFR-Mutated Non-Small-Cell Lung Carcinoma
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Carcinoma, Small Cell
1
Breast Neoplasms
1
Atrial Fibrillation
1
Interventions
pembrolizumab
38
Docetaxel
23
Paclitaxel
20
Trastuzumab
19
Cyclophosphamide
18
Gemcitabine
17
Carboplatin
17
Magnetic Resonance Spectroscopy
16
Radiotherapy
14
Nivolumab
13
Radiosurgery
12
Surveys and Questionnaires
11
Specimen Handling
10
Fulvestrant
10
fludarabine
9
aldesleukin
9
Vinorelbine
9
Blood Specimen Collection
9
Taxes
8
Injections
8
Drug Therapy
8
Cisplatin
8
Capecitabine
8
Bevacizumab
8
Standard of Care
7
Psychiatric Rehabilitation
7
Fluorodeoxyglucose F18
7
Early Intervention, Educational
7
sargramostim
6
palbociclib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Electrocardiography
×
Thoracic
×
Clear all
NCT05927246
2023-07-03
RADAF
Istanbul University
Completed
400 enrolled